‘Stop ripping us off’: Senate grills Novo Nordisk CEO on weight loss drug pricing
Novo Nordisk‘s top executive faced a Senate grilling on Tuesday over the high prices of the company’s weight loss drug Wegovy and diabetes treatment Ozempic, as demand for both injections…